Moreover, anti-DFS70 antibodies were more prevalent in our group of consecutive patients with a history of thrombophilia (11.1%, 7 patients out of 63) than in both published cohorts of healthy individuals (5.8%, 35 patients out of 597 and 3.15%, 29 out of 918 respectively) or our cohort of healthy donors (3.0%, 9 patients out of 300). The gene discussed is PSIP1; the disease is Rare hereditary thrombophilia.